Comments
Glenmark Generics Inc has launched an anti-inflammatory cream in the US market. The company is a US subsidiary of Glenmark Generics, part of Mumbai-based Glenmark Pharmaceuticals. The cream is claimed to provide relief for dermatoses in adults and moderate dermatitis (skin inflammations) in patients under 18.
Derived from Locoid Lipocream, the hydrocortisone butyrate cream, approved for sale in September, will enter a $37-million market in the US. It will enjoy 180 days of exclusivity because it was the first generic company to file for an Abbreviated New Drug Application for the product, Glenmark said in a filing with the BSE.
Glenmark currently boasts 90 authorised products in the US and has 56 drug applications pending approval by the US Food and Drug Administration. The company is looking at technological partnerships to widen its US portfolio, said the release.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.